Diagnosis and treatment of idiopathic pulmonary fibrosis federal guidelines

Abstract

This article contains clinical guidelines and current approaches to diagnosis and treatment of idiopathic pulmonary fibrosis (IPF). The aims of development this guidelines were to improve early detection and efficacy of pharmacological and non-pharmacological therapy of IPF. Achieving these goals indicates improvement in medical care quality for these patients. These guidelines are intended to pulmonologists, therapeutists and other medical specialists, healthcare managers and other healthcare providers.